A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy-Reference-Cited by-同舟云学术

A Hybrid Platform Based on a Bispecific Peptide-Antibody Complex for Targeted Cancer Therapy

Published:2019-01-25 Issue:7 Volume:58 Page:2005-2010
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Yu Byeongjun¹^ORCID,Hwang Dobeen²,Jeon Hyungsu¹,Kim Hyungjun¹,Lee Yonghyun¹,Keum Hyeongseop¹,Kim Jinjoo¹,Lee Dong Yun³,Kim Yujin¹,Chung Junho²,Jon Sangyong¹³⁴^ORCID

Affiliation:

1. KAIST Institute for the BioCentury; Department of Biological Sciences; Korea Advanced Institute of Science and Technology (KAIST); 291 Daehak-ro Daejeon 34141 Republic of Korea

2. Department of Biochemistry and Molecular Biology; Seoul National University College of Medicine; 103 Daehak-ro Seoul 03080 Republic of Korea

3. Graduate School of Medical Science and Engineering; KAIST; 291 Daehak-ro Daejeon 34141 Republic of Korea

4. Center for Precision Bio-Nanomedicine; KAIST; 291 Daehak-ro Daejeon 34141 Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/anie.201811509/fullpdf

Reference39 articles.